Definium Therapeutics News - June 23, 2026

🟢 DFTX is trading 5.2% up today as investors cheer Phase 3 data and analyst upgrades

DFTX is trading 5.2% up at $38.59 as shares rebound from an equity offering pullback, with investors refocusing on positive Phase 3 clinical data for its...

🔴 DFTX is trading 6.9% down today on a $500M equity offering following Phase 3 data surge

DFTX is trading 6.9% down at $34.11 in pre-market action, pulling back from yesterday's significant gains following the announcement of a ~$500 million equity...